Clinical Trials Logo

Secondary Insomnia clinical trials

View clinical trials related to Secondary Insomnia.

Filter by:
  • None
  • Page 1

NCT ID: NCT01804036 Active, not recruiting - Primary Insomnia Clinical Trials

Two Contrasting Interventions for Sleep Management

Start date: March 2013
Phase: Phase 2/Phase 3
Study type: Interventional

This study will determine whether Mind-Body Bridging (MBB), a mindfulness training program is more effective than a common sleep medication, Zolpidem, in treating insomnia. It will also investigate whether MBB is additionally beneficial for co-morbid conditions such as stress, PTSD, depression, etc, compared with that of Zolpidem.

NCT ID: NCT00784875 Completed - Primary Insomnia Clinical Trials

An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia

SLUMBER
Start date: October 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare an investigational drug (LY2624803) with placebo and with zolpidem in the treatment of outpatients with chronic insomnia.

NCT ID: NCT00235365 Withdrawn - Secondary Insomnia Clinical Trials

Metacognitive Therapy for Comorbid Insomnia

Start date: August 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effect of meta-cognitive therapy for insomnia.

NCT ID: NCT00105872 Completed - Insomnia Clinical Trials

Behavioral Insomnia Therapy in Primary Care

Start date: March 2002
Phase: N/A
Study type: Interventional

Insomnia reduces quality of life, increases risks for other illnesses, and enhances health care costs/utilization. Several efficacy studies have shown that Cognitive-Behavioral Therapy (CBT) for insomnia improves sleep and diurnal complaints among highly screened samples; however, its effectiveness among �real-world� primary care patients is yet to be tested. This project is highly relevant to the VA health care mission, given the high prevalence of insomnia in middle-aged and older adults. Pilot data from this VA suggest that 40% of primary care patients report trouble sleeping.